RISK OF CANCER RECURRENCE IN PATIENTS WITH IMMUNE-MEDIATED DISEASES WITH USE OF IMMUNOSUPPRESSIVE THERAPIES: AN UPDATED SYSTEMATIC REVIEW AND META-ANALYSIS.
Fiche publication
Date publication
août 2023
Journal
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
Auteurs
Membres identifiés du Cancéropôle Est :
Pr PEYRIN-BIROULET Laurent
Tous les auteurs :
Gupta A, Peyrin-Biroulet L, Ananthakrishnan AN
Lien Pubmed
Résumé
There is limited data on the safety of immunosuppressive therapies use in individuals with immune-mediated diseases with a history of malignancy, particularly with newer biologic and small molecule treatments.
Mots clés
cancer, immune-mediated diseases, immunosuppression, recurrence
Référence
Clin Gastroenterol Hepatol. 2023 08 12;: